ArticleCellular and molecular life sciences : CMLS2025
RCN1 downregulation-driven endoplasmic reticulum stress impairs endothelial function and diabetic foot ulcer healing.
Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Diabetic foot ulcers (DFUs) are a leading cause of disability and mortality, with endothelial dysfunction playing a key role in the development of non-healing ulcers. A primary driver of endothelial cell impairment in this context is endoplasmic reticulum (ER) stress, triggered by glycolipotoxicity, though the underlying mechanisms are not fully understood. In this study, we observed that diabetic mice displayed poor ulcer healing associated with reduced angiogenesis and downregulated Reticulocalbin 1 (RCN1) expression. Proteomic analysis in human umbilical vein endothelial cells (HUVECs) identified a strong link between RCN1 and the damaging effects of glycolipotoxicity on endothelial cell function, leading to impaired tubule formation, reduced migratory capacity, and increased apoptosis in endothelial cells. Mechanistic RNA sequencing analysis highlighted a significant role for RCN1 in regulating ER function. RCN1 overexpression alleviated ER stress by reducing Protein kinase R-like endoplasmic reticulum kinase (PERK) phosphorylation and C/EBP homologous protein (CHOP) expression, both induced by glycolipotoxicity or Thapsigargin (TG), while RCN1 silencing intensified these effects. Additionally, TRIM11-mediated ubiquitination, influenced by glycolipotoxicity, regulated RCN1 stability, specifically promoting angiogenesis through RCN1 modulation. RCN1 overexpression accelerated ulcer healing in diabetic mice by suppressing ER stress proteins and enhancing angiogenesis, whereas RCN1 inhibition further delayed ulcer healing. In human DFU samples, proteomic analysis revealed that low RCN1 levels were linked to disrupted ER functional proteins, with RCN1 serum levels decreasing as diabetes progressed to DFU. Following surgical debridement treatment, RCN1 levels increased in patients with improved DFU healing outcomes. These findings suggest that ER stress, initiated by RCN1 inhibition in response to glycolipotoxicity, leads to endothelial dysfunction and apoptosis, ultimately contributing to the non-healing of DFUs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.